Stockreport

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting [Yahoo! Finance]

Xilio Therapeutics, Inc.  (XLO) 
PDF biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced multiple upcoming poster presen [Read more]